Hyperhidrosis Treatment Market Updates : Projected to Surpass USD 950.7 Million by 2031

Allied Market Research published a report, titled, "Hyperhidrosis Treatment Market by Type (Axillary hyperhidrosis, Palmar hyperhidrosis, Plantar hyperhidrosis, Others), by Treatment (Botulinum toxin injections, Topical treatment, Oral medication), by Age (Below 50 years, Above 50 years): Global Opportunity Analysis and Industry Forecast, 2021-2031."

According to the report, the global hyperhidrosis treatment industry generated $575.3 million in 2021, and is projected to reach $950.7 million by 2031, manifesting a CAGR of 5.1% from 2022 to 2031.

𝐏𝐫𝐢𝐦𝐞 𝐝𝐞𝐭𝐞𝐫𝐦𝐢𝐧𝐚𝐧𝐭𝐬 𝐨𝐟 𝐠𝐫𝐨𝐰𝐭𝐡
Rise in prevalence of diseases such as axillary hyperhidrosis in developed countries, expanding product launches and product approvals, and surge in demand for improved healthcare services drive the growth of the global hyperhidrosis treatment market. However, lack of awareness and unfavorable reimbursement scenario restrain the market growth. On the other hand, rise in utilization topical treatment and technological advancements present new opportunities in the coming years.

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝑪𝒐𝒑𝒚 𝒐𝒇 𝑹𝒆𝒑𝒐𝒓𝒕 https://www.alliedmarketresearch.com/request-sample/17972

𝐓𝐡𝐞 𝐚𝐱𝐢𝐥𝐥𝐚𝐫𝐲 𝐡𝐲𝐩𝐞𝐫𝐡𝐢𝐝𝐫𝐨𝐬𝐢𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐥𝐞𝐚𝐝 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝
Based on type, the axillary hyperhidrosis segment accounted for the highest market share in 2021, contributing to around three-fifths of the global hyperhidrosis treatment market, and is projected to maintain its lead position during the forecast period. Moreover, this segment is projected to manifest the largest CAGR of 5.4% from 2022 to 2031. This is due to high incidence of axillary hyperhidrosis among younger as well as adult generation. The report also analyzes the segments including palmar hyperhidrosis, plantar hyperhidrosis, and others.

𝐓𝐡𝐞 𝐭𝐨𝐩𝐢𝐜𝐚𝐥 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞 𝐢𝐭𝐬 𝐝𝐨𝐦𝐢𝐧𝐚𝐧𝐭 𝐬𝐡𝐚𝐫𝐞 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝
Based on treatment, the topical treatment segment contributed to the highest market share in 2021, accounting for more than three-fifths of the global hyperhidrosis treatment market, and is projected to continue its dominant share throughout the forecast period. Moreover, this segment is estimated to manifest the highest CAGR of 5.4% from 2022 to 2031. This is attributed to product innovation and effective & rapid effects of the topicals. The report also analyzes the segments including botulinum toxin injections and oral medication.

𝐓𝐡𝐞 𝐛𝐞𝐥𝐨𝐰 50 𝐲𝐞𝐚𝐫𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞 𝐢𝐭𝐬 𝐡𝐢𝐠𝐡𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝
Based on age, the below 50 years segment accounted for the largest market share in 2021, holding around three-fifths of the global hyperhidrosis treatment market, and is estimated to continue its highest contribution throughout the forecast period. In addition, this segment is projected to register the fastest CAGR of 5.3% from 2022 to 2031. This is due to high incidence of hyperhidrosis disease in below 50-year age group. The report also analyzes the above 50 years segment.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲- https://www.alliedmarketresearch.com/purchase-enquiry/17972

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐬𝐭𝐚𝐭𝐮𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝
Based on region, North America held the largest market share in 2021, accounting for more than two-fifths of the global hyperhidrosis treatment market, and will maintain its leadership status throughout the forecast period. This is attributed to technological advancements in hyperhidrosis treatment, high incidence of disease, presence of key and robust hospital infrastructure in the region. However, Asia-Pacific is expected to grow at the largest CAGR of 5.9% from 2022 to 2031, owing to development of healthcare infrastructure and increase in investments projects in the region.

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
AbbVie Inc.
Avanor Healthcare Ltd.
Brickbell Biotech, Inc.
Dr August Wolff GmbH & Co. Kg Drugs
Dr. Reddy's Laboratories Ltd.
Eirion Therapeutics, Inc.
Eli Lilly and Company
Hugel, Inc.
Kaken Pharmaceutical Co., Ltd.
Intas Pharmaceuticals Ltd.
Roivant Sciences Ltd.
Theravida, Inc.

The report analyzes these key players and highlights various strategies such as new product launches, partnerships, expansion, and others to raise their market penetration and strengthen their position in the market. The report offers a detailed analysis that outlines product portfolio, operating segments, business performance, and key developments of each market player.

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞- https://www.alliedmarketresearch.com/hyperhidrosis-treatment-market-A17523

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧-
𝐅𝐞𝐫𝐭𝐢𝐥𝐢𝐭𝐲 𝐒𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/fertility-supplements-market-A07134

𝐀𝐧𝐞𝐬𝐭𝐡𝐞𝐬𝐢𝐚 𝐌𝐚𝐜𝐡𝐢𝐧𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/anesthesia-machinery-market-A06271

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧-
𝐎𝐩𝐡𝐭𝐡𝐚𝐥𝐦𝐢𝐜 𝐏𝐞𝐫𝐢𝐦𝐞𝐭𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/ophthalmic-perimeter-market-A13063

𝐇𝐞𝐚𝐥𝐭𝐡 𝐂𝐨𝐚𝐜𝐡𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/health-coaching-market-A13404

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.